| |
|
|
|
GenMark Diagnostics Inc.  
|
|
6.31 0.07 (0.01%) |
10-17 16:00 |
|
Open: |
6.23 |
Pre close: |
6.24 |
Target:
|
8.36
|
|
High: |
6.43 |
Low: |
6.145 |
Resistance:
|
7.16
8.32
|
|
Volume: |
195,635 |
Market Cap: |
352M |
Support:
|
5.28
4.39
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.18
 |
MACD |
MACD(12,26):
|
-0.41 |
|
MA(20): |
6.89  |
Signal(12,26,9): |
-0.35 |
|
MA(100): |
7.16 |
Stochastic Oscillator |
%K(14,3):
|
34.34 |
|
MA(250): |
6.10 |
%D(3): |
28.73 |
|
Average Volume(K) |
3-Month: |
25004
|
52-Week |
High:
|
8.81 |
|
10-Days: |
25222 |
Low: |
3.63 |
|
RSI |
RSI(14):
|
34.80 |
Change(%): |
-19.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.050 |
Return on Equity (ttm) |
-79.8 |
Shares Out. (M) |
55.75 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-46.9 |
Shares Float (M) |
52.60 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.16 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
20.9 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.075 |
Shares Short (K) |
4859 |
|
Book Value (p.s.) |
6.870 |
EBITDA (p.s.) |
-0.234 |
P/E |
-6.01 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.92 |
|
Profit Margin |
-81.73 |
Operating Cash Flow
(M) |
-41.69 |
P/S |
305897824.00 |
|
Operating Margin |
-87.46 |
Levered Free Cash Flow
(M) |
-20.51 |
P/CF |
-8.44 |
|
|
|
|
|
|
